Maurice Lévy on his 30 years in charge of Publicis Groupe

Maurice Lévy on his 30 years in charge of Publicis Groupe

Midway through Campaign's audience with Publicis Groupe's Maurice Lévy, a heavily French-accented voice exclaims, "Now it is time for the real boss to arrive."

Five things for pharma marketers to know: Monday, November 6, 2017

Five things for pharma marketers to know: Monday, November 6, 2017

Valeant sells Addyi back to Sprout; some advertisers halt business with Outcome Health; Amgen cuts R&D jobs

P&G slashed the number of sites it ran ads on by nearly 70% after YouTube brand safety scandal

P&G slashed the number of sites it ran ads on by nearly 70% after YouTube brand safety scandal

In April, a month or so after brands were accused of funding terrorist videos on YouTube, Procter & Gamble cut down the number of sites its ads ran on by 69%.

Barby Ingle on the challenges of healthcare influencer marketing

Barby Ingle on the challenges of healthcare influencer marketing

The blogger talks the challenges of influencer marketing in healthcare, chronic disease, and big brand activations.

Five things for pharma marketers to know: Friday, November 3, 2017

Five things for pharma marketers to know: Friday, November 3, 2017

Experimental Gilead and GSK HIV drugs are expected to compete; GSK R&D head resigns; Valeant subsidiary scores eye-drug approval

Five things for pharma marketers to know: Thursday, November 2, 2017

Five things for pharma marketers to know: Thursday, November 2, 2017

Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III

Pfizer bolsters Eucrisa launch with two DTC campaigns

Pfizer bolsters Eucrisa launch with two DTC campaigns

Forecasts anticipate sales of $1.3 billion in five years.

Front seat to the comms evolution: Abbott's Melissa Brotz

Front seat to the comms evolution: Abbott's Melissa Brotz

The divisional VP and head of public affairs has seen it all, including the transformation from a traditional comms organization to a more dynamic and content-led group.

Analysts agree with WPP that threat from consultancies has been 'overhyped'

Analysts agree with WPP that threat from consultancies has been 'overhyped'

During its third quarter earnings call yesterday, WPP dismissed the threat from management consultants as "overhyped". Analysts concur.

Five things for pharma marketers to know: Wednesday, November 1, 2017

Five things for pharma marketers to know: Wednesday, November 1, 2017

Drug industry spends nearly $50 million to fight drug-price referendum; Novartis weighs sales of generic unit; ICER to evaluate all newly approved drugs

MM&M and PRWeek unveil the 2017 Health Influencer 50

MM&M and PRWeek unveil the 2017 Health Influencer 50

MM&M and PRWeek have revealed the 2017 Health Influencer 50, a list honoring professionals across the health spectrum for their passion, determination, and innovative thinking that has helped guide the industry through two turbulent and exciting decades.

Speaker bureaus must change to stay relevant, experts say

Speaker bureaus must change to stay relevant, experts say

To remain relevant, speakers bureaus must evolve to a strategic marketing tactic with personalized messaging to the customer.

Five things for pharma marketers to know: Tuesday, October 31, 2017

Five things for pharma marketers to know: Tuesday, October 31, 2017

Pfizer Q3 revenue driven by Prevnar sales; President Trump's opioid panel presents draft to combat crisis; Novartis seeks FDA approval for CAR-T therapy Kymriah

How Aubagio became the most switched-to oral MS drug

How Aubagio became the most switched-to oral MS drug

Second to market and dismissed as inferior to the competition, Sanofi's Aubagio seemed destined for lower-tier status. Here's how it overcame the initial obstacles and, five years later, become a potent market force

Five things for pharma marketers to know: Monday, October 30, 2017

Five things for pharma marketers to know: Monday, October 30, 2017

Novartis to acquire French biotech in bid to develop new cancer therapies; FDA hires former Mylan exec as comms adviser; health system sees drop in opioid scripts

Doctors who receive gifts from industry prescribe more branded drugs: study

Doctors who receive gifts from industry prescribe more branded drugs: study

In 2013, Medicare Part D prescribers who received a gift from a drugmaker prescribed 8% more brand-name drugs.

GCI Health, HealthyWomen, Redbook partner to learn about women's health

GCI Health, HealthyWomen, Redbook partner to learn about women's health

The HealthiHER project has commissioned a survey of women aged 30 to 60 to inform future campaigns.

Porter Novelli wins lucrative multi-year CSR brief with Johnson & Johnson

Porter Novelli wins lucrative multi-year CSR brief with Johnson & Johnson

Porter Novelli has been appointed to lead a new global CSR brief for pharma and consumer goods giant Johnson & Johnson, as the company faces a major reputation challenge in the US.

Five things for pharma marketers to know: Friday, October 27, 2017

Five things for pharma marketers to know: Friday, October 27, 2017

CVS Health reportedly in talks to acquire Aetna; Amazon acquires wholesale pharmacy licenses; Merck says June cyberattack disrupted global operations

StoneArch hires Marcia Miller as new president

StoneArch hires Marcia Miller as new president

Optum vet Miller replaces Jessica Boden.

Five things for pharma marketers to know: Thursday, October 26, 2017

Five things for pharma marketers to know: Thursday, October 26, 2017

Non-profit challenges Gilead's Sovaldi patent; The Medicines Company to cut hundreds of jobs; Amgen ends R&D for experimental CETP drug

Why haven't biosimilars gained ground in the U.S.?

Why haven't biosimilars gained ground in the U.S.?

Two years after the first biosimilar approval in the U.S., biosimilars have yet to match sales forecasts. What is their path forward?

Five things for pharma marketers to know: Wednesday, October 25, 2017

Five things for pharma marketers to know: Wednesday, October 25, 2017

FDA develops resources about biosimilars for HCPs; Biogen negotiates royalties for experimental Alzheimer's drug; GSK Q3 sales driven by HIV, respiratory drugs

W2O looks to eliminate confusion with network rebrand

W2O looks to eliminate confusion with network rebrand

The agency network is rebranding five subsidiaries under the W2O banner.

10 questions for PhRMA's CEO Stephen Ubl

10 questions for PhRMA's CEO Stephen Ubl

Trade group PhRMA's CEO talks about his first year in the job amid public outrage about price gouging.

Five things for pharma marketers to know: Tuesday, October 24, 2017

Five things for pharma marketers to know: Tuesday, October 24, 2017

FDA approves Alexion's Soliris for another rare disease; Sun Pharma debuts companion mobile app for acne drug; Hurricane halts manufacturing in Puerto Rico

Read the October 2017 digital edition

Read the October 2017 digital edition

Read the October 2017 issue in its entirety, including our Career and Salary Survey.

Sanofi asks the world 'How are you?' in latest corporate branding campaign

Sanofi asks the world 'How are you?' in latest corporate branding campaign

The Paris-based pharma company debuted a brand campaign and signature last week.

Five things for pharma marketers to know: Monday, October 23, 2017

Five things for pharma marketers to know: Monday, October 23, 2017

Biosimilars could save $54 billion in next decade; White House requests drug-pricing task force; FDA approves GSK shingle vaccine

Merck to axe 1,800 sales positions, form new chronic-care sales team

Merck to axe 1,800 sales positions, form new chronic-care sales team

The drugmaker eliminated its U.S. primary care, disease-focused endocrinology, and hospital chronic-care sales teams.

My career in 5 executions: Saatchi & Saatchi Wellness' Kathy Delaney

My career in 5 executions: Saatchi & Saatchi Wellness' Kathy Delaney

From IKEA to eye-opening health campaigns, S&S Wellness' CCO helps turn emotion into action.

Phoenix House tries to change the perception of rehab

Phoenix House tries to change the perception of rehab

The organization rolled out a video this week as part of its Live Unaddicted campaign to change the perception of addiction treatment.

Five things for pharma marketers to know: Friday, October 20, 2017

Five things for pharma marketers to know: Friday, October 20, 2017

Merck lays off 1,800 employees, launches new sales force; Celgene ends development of Crohn's disease drug; PBMs come under increased scrutiny

Area 23, 2e Creative, and Digitas Health win big at 2017 MM&M Awards

Area 23, 2e Creative, and Digitas Health win big at 2017 MM&M Awards

Area 23 netted three gold awards, and 2e Creative won Small Agency of the Year for the third year in a row.

Up to 20% of pharma brands moving digital media spend to point-of-care

Up to 20% of pharma brands moving digital media spend to point-of-care

Two point-of-care companies have received hundreds of millions of dollars in funding. One of them, Outcome Health, is facing allegations about padding data.

Five things for pharma marketers to know: Thursday, October 19, 2017

Five things for pharma marketers to know: Thursday, October 19, 2017

The FDA approves Kite's CAR-T therapy; Omnicom reports strong Q3 performance for healthcare agencies; Hearst to acquire Rodale, up health presence

Five things for pharma marketers to know: Wednesday, October 18, 2017

Five things for pharma marketers to know: Wednesday, October 18, 2017

More than half of doctors say patients make critical, racist, or sexist comments; Anthem to launch its own PBM; drugmakers face criticism for waste

Novo's experimental diabetes drug likely to compete with Trulicity

Novo's experimental diabetes drug likely to compete with Trulicity

An FDA advisory committee is scheduled to vote Wednesday on whether to approve Novo's semaglutide, which, if approved, could steal market share from Eli Lilly's Trulicity.

Wellpepper wins Alexa Diabetes Challenge

Wellpepper wins Alexa Diabetes Challenge

The health startup's system has a foot scanner that can take photos of a patient's feet and can look for potential foot ulcers using a machine learning image classifier.

Five things for pharma marketers to know: Tuesday, October 17, 2017

Five things for pharma marketers to know: Tuesday, October 17, 2017

J&J reports 15% lift in pharma sales in Q3; Apple reportedly considers buying medical clinics; survey finds need for digital investment in payer marketing

Drugmakers begin to up media controls, in bid to clean up digital ad supply

Drugmakers begin to up media controls, in bid to clean up digital ad supply

Like its consumer-products cousins, pharma marketers are exercising more discipline over online media. Will it yield similar results?

Five things for pharma marketers to know: Monday, October 16, 2017

Five things for pharma marketers to know: Monday, October 16, 2017

FDA briefing document affirms diabetes drug's efficacy; J&J debuts new tools to improve adherence; AZ says cancer drug data was falsified

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.

Five things for pharma marketers to know: Friday, October 13, 2017

Five things for pharma marketers to know: Friday, October 13, 2017

Outcome Health reportedly misled advertisers; FDA committee recommends gene therapy; Avanir drug is highly prescribed by docs paid by company

Muscular Dystrophy Association taps Lynn O'Connor Vos as CEO

Muscular Dystrophy Association taps Lynn O'Connor Vos as CEO

The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.

Five things for pharma marketers to know: Thursday, October 12, 2017

Five things for pharma marketers to know: Thursday, October 12, 2017

Merck scraps plans for cholesterol drug; oncologist describes how he tells people about his work; researchers question list of side effects in DTC ads

Nonprofits focus attention on metastatic breast cancer this October

Nonprofits focus attention on metastatic breast cancer this October

Susan G. Komen and the Breast Cancer Research Foundation are focusing on raising awareness and research money for the deadliest forms of the disease.

Five things for pharma marketers to know: Wednesday, October 11, 2017

Five things for pharma marketers to know: Wednesday, October 11, 2017

Pfizer considers sale of its consumer healthcare business; Express Scripts moves into patient benefit management; China to speed up drug approvals

Five things for pharma marketers to know: Tuesday, October 10, 2017

Five things for pharma marketers to know: Tuesday, October 10, 2017

Patients complain about positive healthcare ads; some drugmakers skirt Open Payment rules; new law requires disclosure of drug price hikes in California

Astellas turns to 'corporate branding 2.0'

Astellas turns to 'corporate branding 2.0'

The communications team, led by Jeff Winton, is again researching Astellas' reputation for an updated picture on where the campaign has gotten them so far.

Five things for pharma marketers to know: Friday, October 6, 2017

Five things for pharma marketers to know: Friday, October 6, 2017

AbbVie to pay $140 million to AndroGel patient; Trump likely to roll back birth-control mandate; patients more likely to respond to expensive drugs

Five things for pharma marketers to know: Thursday, October 5, 2017

Five things for pharma marketers to know: Thursday, October 5, 2017

Cigna will no longer cover OxyContin; the AMA no longer supports price-fixing to lower drug prices; Gottlieb is not in favor of 'right-to-try' laws

How Walgreens overcomes 'consumer complacency' during flu-shot season

How Walgreens overcomes 'consumer complacency' during flu-shot season

In the 2015-16 flu season, more than 145 million doses were distributed by manufacturers, according to the Centers for Disease Control and Prevention, but only 41% of American adults received a vaccine.

Five things for pharma marketers to know: Wednesday, October 4, 2017

Five things for pharma marketers to know: Wednesday, October 4, 2017

The FDA approves Mylan's Copaxone generic; 3 out of every 1,000 Americans face $50,000 in drug costs; some ACA premiums may rise by 50%

How a cancer nonprofit is using Comic Con in bid for new donors

How a cancer nonprofit is using Comic Con in bid for new donors

DKMS worked with Marino on PR for the campaign and with Area 23 on its Comic Con booth.

Medical journal ad spend in H1 2017: All the data in one place

Medical journal ad spend in H1 2017: All the data in one place

The top three most advertised brands were GlaxoSmithKline's Breo Ellipta, Eli Lilly's Trulicity, and Boehringer Ingelheim's Jardiance.

Five things for pharma marketers to know: Tuesday, October 3, 2017

Five things for pharma marketers to know: Tuesday, October 3, 2017

The FDA wants to improve the generic drug approval process; Allergan CEO responds to criticism of patent deal; breast cancer death rate dropped 40%

The professional paths of 8 pharma execs

The professional paths of 8 pharma execs

The successes of these pharma execs show that there's no one path to professional bliss.

How HUBs will evolve in the ever-changing healthcare landscape

How HUBs will evolve in the ever-changing healthcare landscape

The need to simplify access to treatment while finding new ways to keep patients engaged in their health and adherent is an undeniably growing trend.

Five things for pharma marketers to know: Monday, October 2, 2017

Five things for pharma marketers to know: Monday, October 2, 2017

The FDA tells 75 opioid drugmakers to fund training efforts; epilepsy drug reduces seizure frequency; FDA approves Novo's fast-acting mealtime insulin

AbelsonTaylor's Jay Carter on the key to retaining top talent

AbelsonTaylor's Jay Carter on the key to retaining top talent

Now that Facebook, Apple, and Google have set their sights on healthcare, agencies find themselves under pressure from yet another flank.

Pharma marketing salaries reach new heights, up 12.7% in 2017

Pharma marketing salaries reach new heights, up 12.7% in 2017

Salaries are up — by a lot — and marketers are enthusiastic about their career prospects.

Read the September 2017 digital edition

Read the September 2017 digital edition

Read the September 2017 issue in its entirety, including how marketing can save clinical trials.

Five things for pharma marketers to know: Friday, September 29, 2017

Five things for pharma marketers to know: Friday, September 29, 2017

Merck to stop developing hep.-C drugs; FDA approves new Lilly breast-cancer drug; California bill would outlaw co-pay cards

Five things for pharma marketers to know: Thursday, September 28, 2017

Five things for pharma marketers to know: Thursday, September 28, 2017

Universities stock vending machines with women's health products; AbbVie pays to delay Amgen's Humira biosimilar; more states likely to introduce off-label bills

WPP pulls out of Eurobest, threatens to leave Cannes

WPP pulls out of Eurobest, threatens to leave Cannes

A leaked email chain shows that WPP intends to withdraw from Ascential's Eurobest awards in London and is in discussions with the organizer about Cannes Lions.

Bank: Publicis and WPP are takeover targets, and Accenture is a 'credible buyer'

Bank: Publicis and WPP are takeover targets, and Accenture is a 'credible buyer'

Accenture or CapGemini are more likely to acquire the global agency networks than a Google or Oracle, according to a leading French bank.

Infographic | How often are drugmakers sharing clinical-trial data?

Infographic | How often are drugmakers sharing clinical-trial data?

The answer: it depends on what phase the trial is in.

Five things for pharma marketers to know: Wednesday, September 27, 2017

Five things for pharma marketers to know: Wednesday, September 27, 2017

AbbVie adds context to CEO's comments on drug pricing; Pandora makes a play for pharma ad dollars; shortages expected of drugs manufactured in Puerto Rico

One-quarter of global marketers report digital ads next to extremist content

One-quarter of global marketers report digital ads next to extremist content

Some of the world's marketers have reported specific examples of where their digital advertising appeared alongside offensive and compromising content.

The ugly truth about advertising's gender bias, and how to change it

The ugly truth about advertising's gender bias, and how to change it

Execs from JWT, J&J, and DanoneWeave react to the results of a new JWT/Geena Davis Institute study.

Five things for pharma marketers to know: Tuesday, September 26, 2017

Five things for pharma marketers to know: Tuesday, September 26, 2017

Patient assistance nonprofit contacted in Aegerion probe; most heavily marketed drugs in Canada offer little therapeutic value; the FDA pans Duchenne drug

Drugmakers turn to social — not TV — to market drugs to women

Drugmakers turn to social — not TV — to market drugs to women

Still, most experts characterize this year's newly approved women's health drugs as modest improvements rather than groundbreaking advances in medicine.

How Pablo Graiver plans to solve the problem of clinical-trial recruitment

How Pablo Graiver plans to solve the problem of clinical-trial recruitment

The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.

Top 25 women's health brands, based on U.S. sales in 2016

Top 25 women's health brands, based on U.S. sales in 2016

Amgen's Prolia tops the list, according to data compiled by EvaluatePharma.

Healthcare agencies re-evaluate tactics to retain talent

Healthcare agencies re-evaluate tactics to retain talent

The best marketers possess a mix of scientific know-how, digital dexterity, and unflappability. To keep them, agencies need to revise their thinking and tactics.

Five things for pharma marketers to know: Monday, September 25, 2017

Five things for pharma marketers to know: Monday, September 25, 2017

The FDA declines to approve an opioid and a treatment for rheumatoid arthritis; KKR closes WebMD buyout; 60% of teens have received the HPV vaccine

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

The health insurance startup launched a campaign this week that urges people to get covered.

Five things for pharma marketers to know: Friday, September 22, 2017

Five things for pharma marketers to know: Friday, September 22, 2017

Express Scripts' Miller says new models needed to pay for CAR-T; FDA warns about Intercept drug deaths; CVS puts limits on opioid scripts

New pharma CEOs to face payer, pricing challenges

New pharma CEOs to face payer, pricing challenges

They are tasked with addressing an increasingly tough payer environment and ongoing criticism of the industry's drug-pricing practices.

Wieden+Kennedy and The Atlantic win ADCOLOR's Ad of the Year for Typecast

Wieden+Kennedy and The Atlantic win ADCOLOR's Ad of the Year for Typecast

Blood Equality for GMHC by FCB Health was another honoree for Ad of the Year.

Five things for pharma marketers to know: Thursday, September 21, 2017

Five things for pharma marketers to know: Thursday, September 21, 2017

Nestle to refocus Galderma's skin health R&D; Amazon is reportedly in talks with PBMs; most Americans do not actively read science news

Co-pay cards unlock the key to patient engagement

Co-pay cards unlock the key to patient engagement

Beyond providing access, co-pay cards represent a starting point to more powerful patient engagement.

At ADCOLOR, Five Woke Women challenge perceptions of identity in the workplace

At ADCOLOR, Five Woke Women challenge perceptions of identity in the workplace

A "seat at the table" isn't enough, says Oath's Allison Allen, in wide-ranging discussion at annual diversity conference.

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

Facebook itself has more than six million health-related groups.

Five things for pharma marketers to know: Wednesday, September 20, 2017

Five things for pharma marketers to know: Wednesday, September 20, 2017

Pfizer sues J&J over Remicade contracts; drugmakers trim sales forces for rare-disease drugs; Roche's oncology business under siege from biosimilars

New Cologuard ad tries humor to make colon screening accessible

New Cologuard ad tries humor to make colon screening accessible

Exact Sciences has found success by marketing Cologuard in ads airing on networks like MSNBC, CNN, and Fox News.

Five things for pharma marketers to know: Tuesday, September 19, 2017

Five things for pharma marketers to know: Tuesday, September 19, 2017

Only three of the seven FDA-approved biosimilars are available for sale; Teva to sell off women's health portfolio; the FDA approves GSK's COPD combo

American Cancer Society: 'We are more than just a research organization'

American Cancer Society: 'We are more than just a research organization'

The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.

UDG Healthcare acquires MicroMass, for up to $75.8 million

UDG Healthcare acquires MicroMass, for up to $75.8 million

The company also this year has purchased Vynamic and Cambridge BioMarketing.

Five things for pharma marketers to know: Monday, September 18, 2017

Five things for pharma marketers to know: Monday, September 18, 2017

Insurers rarely require prior authorization for opioids; court of appeals voids J&J win in Advil ads suit; new California law to address drug pricing

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.

Is your brand's voice, male, female, human or mineral?

Is your brand's voice, male, female, human or mineral?

The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.

Five things for pharma marketers to know: Friday, September 15, 2017

Five things for pharma marketers to know: Friday, September 15, 2017

The FDA approves first cancer biosimilar; it also approves Bayer's new lymphoma drug; clinical-trial participation for gynecological cancer drops

Sheryl Sandberg: 'Facebook must bring people together to do good'

Sheryl Sandberg: 'Facebook must bring people together to do good'

Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.

Five things for pharma marketers to know: Thursday, September 14, 2017

Five things for pharma marketers to know: Thursday, September 14, 2017

One-third of clinical trials are never publicly registered; ICER revises PCSK9 cost-effectiveness analysis; flu shot linked to miscarriages

Giant brings on new brand experience lead, as Armstrong departs

Giant brings on new brand experience lead, as Armstrong departs

Aaron Sklar, formerly of Welltok, replaces Christine Armstrong, who moved on to a Silicon Valley health startup.

Q&A: On being a working mom

Q&A: On being a working mom

Guidemark Health's Tina Fascetti offers Medela's Katie Busse advice on being a working mother in healthcare marketing.

Five things for pharma marketers to know: Wednesday, September 13, 2017

Five things for pharma marketers to know: Wednesday, September 13, 2017

FDA closes pediatric study loophole; little evidence outcomes-based contracts are working; PBMs lobby against transparency efforts